FDA issued a Warning Letter to Zhejiang Bangli Medical Products Co., Ltd on 1/26/2017 as a result of this inspection.
483 Zhejiang Bangli Medical Products Aug 2016

483 Zhejiang Bangli Medical Products Aug 2016

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Bangli Medical Products - Yongkang City, China facility and issued 11 inspectional observations (via FDA 483) on 17 Aug 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 11
  • Inspection end: 17 Aug 2016
  • Location: Yongkang City, China
  • FEI: 3007028032
Add To Cart